LIVANOVA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.53 USD | +0.78% |
|
+6.12% | +7.33% |
| Mar. 20 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
| Mar. 20 | Sector Update: Health Care Stocks Down Wednesday Afternoon | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,651 | 3,218 | 4,654 | 2,973 | 2,787 | 2,996 | - | - |
| Enterprise Value (EV) 1 | 3,900 | 3,620 | 4,685 | 2,973 | 2,796 | 2,894 | 2,766 | 2,996 |
| P/E ratio | -23.5 x | -9.33 x | -32.6 x | -34.5 x | 162 x | 46 x | 33.3 x | 14.2 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 3.37 x | 3.44 x | 4.49 x | 2.91 x | 2.42 x | 2.48 x | 2.36 x | 2.24 x |
| EV / Revenue | 3.6 x | 3.88 x | 4.52 x | 2.91 x | 2.42 x | 2.39 x | 2.18 x | 2.24 x |
| EV / EBITDA | 18.6 x | 28.6 x | 26.1 x | 17.7 x | 14.4 x | 11.1 x | 9.7 x | 9.99 x |
| EV / FCF | -32,068,049 x | -31,646,580 x | - | 68,487,949 x | 70,074,600 x | - | - | - |
| FCF Yield | -0% | -0% | - | 0% | 0% | - | - | - |
| Price to Book | 2.63 x | 2.88 x | 3.6 x | - | 2.18 x | 2.16 x | 1.98 x | - |
| Nbr of stocks (in thousands) | 48,400 | 48,596 | 53,225 | 53,523 | 53,871 | 53,956 | - | - |
| Reference price 2 | 75.43 | 66.21 | 87.43 | 55.54 | 51.74 | 55.53 | 55.53 | 55.53 |
| Announcement Date | 2/26/20 | 2/24/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,084 | 934.2 | 1,035 | 1,022 | 1,154 | 1,209 | 1,268 | 1,335 |
| EBITDA 1 | 210 | 126.5 | 179.3 | 167.5 | 194 | 260.1 | 285.1 | 300 |
| EBIT 1 | 179.7 | 97.5 | 154.8 | 145.1 | 169.3 | 215 | 239.6 | 269.8 |
| Operating Margin | 16.57% | 10.44% | 14.95% | 14.2% | 14.68% | 17.78% | 18.9% | 20.21% |
| Earnings before Tax (EBT) | -185.7 | -344 | -124.5 | -75.1 | -81.2 | - | - | - |
| Net income 1 | -155.2 | -345 | -135.8 | -86.2 | 17.5 | 57.07 | 197.4 | 223.6 |
| Net margin | -14.31% | -36.93% | -13.12% | -8.44% | 1.52% | 4.72% | 15.57% | 16.75% |
| EPS 2 | -3.210 | -7.100 | -2.680 | -1.610 | 0.3200 | 1.207 | 1.668 | 3.908 |
| Free Cash Flow | -121.6 | -114.4 | - | 43.4 | 39.9 | - | - | - |
| FCF margin | -11.22% | -12.25% | - | 4.25% | 3.46% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | 25.91% | 20.57% | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | 228% | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/26/20 | 2/24/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 253.2 | 270.1 | 240.2 | 254.2 | 252.6 | 274.9 | 263.4 | 293.9 | 286.1 | 310.1 | 278.2 | 305.9 | 298.1 | 325.8 | 290.9 |
| EBITDA 1 | 54.1 | 46.21 | 34 | 38.9 | 42.1 | 52.5 | 32.8 | 55.5 | 51.6 | 54.1 | 42.43 | 64.82 | 64.48 | 76.57 | 59 |
| EBIT 1 | 47.9 | 40.2 | 28.4 | 33.4 | 36.6 | 46.8 | 26.8 | 49.5 | 45 | 48 | 35.06 | 56.74 | 55.07 | 68.19 | 43.95 |
| Operating Margin | 18.92% | 14.88% | 11.82% | 13.14% | 14.49% | 17.02% | 10.17% | 16.84% | 15.73% | 15.48% | 12.6% | 18.55% | 18.48% | 20.93% | 15.11% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net income 1 | -42.2 | -5.1 | 3 | 16.4 | -107.3 | 1.7 | 7.4 | 1.2 | -7.3 | 16.3 | 0.15 | 17.2 | 16.75 | 28.55 | 12 |
| Net margin | -16.67% | -1.89% | 1.25% | 6.45% | -42.48% | 0.62% | 2.81% | 0.41% | -2.55% | 5.26% | 0.05% | 5.62% | 5.62% | 8.76% | 4.13% |
| EPS 2 | -0.8200 | -0.1000 | 0.0600 | 0.3000 | -2.010 | 0.0300 | 0.1400 | 0.0200 | -0.1400 | 0.3000 | 0.0633 | 0.3367 | 0.3567 | 0.5533 | 0.2200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/3/21 | 2/23/22 | 5/4/22 | 8/3/22 | 11/2/22 | 2/22/23 | 5/3/23 | 7/26/23 | 11/1/23 | 2/21/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 249 | 403 | 31.5 | - | 8.7 | - | - | - |
| Net Cash position 1 | - | - | - | - | - | 102 | 231 | - |
| Leverage (Debt/EBITDA) | 1.187 x | 3.184 x | 0.1759 x | - | 0.0448 x | - | - | - |
| Free Cash Flow | -122 | -114 | - | 43.4 | 39.9 | - | - | - |
| ROE (net income / shareholders' equity) | 10.4% | 4.95% | 8.88% | -6.89% | 12.2% | 12.4% | 12.4% | - |
| ROA (Net income/ Total Assets) | -6.26% | -14.3% | 4.64% | -3.83% | 6.43% | 1.9% | 2.7% | 3.6% |
| Assets 1 | 2,481 | 2,412 | -2,928 | 2,248 | 272 | 3,004 | 7,311 | 6,211 |
| Book Value Per Share 2 | 28.60 | 23.00 | 24.30 | - | 23.70 | 25.70 | 28.00 | - |
| Cash Flow per Share 2 | -1.880 | -1.630 | - | 1.310 | 1.380 | 2.650 | 3.010 | - |
| Capex 1 | 28 | 35 | 25.5 | 26.5 | 35 | 30.2 | 31.5 | 30 |
| Capex / Sales | 2.58% | 3.75% | 2.46% | 2.6% | 3.03% | 2.5% | 2.48% | 2.25% |
| Announcement Date | 2/26/20 | 2/24/21 | 2/23/22 | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
55.53
USD
Average target price
66.1
USD
Spread / Average Target
+19.03%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.33% | 3B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- LIVN Stock
- Financials LivaNova PLC
